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Antithrombotic management in patients with atrial fibrillation
undergoing stent implantation: An assessment of the ESC guide-
lines adherence
Yann Ancedy, Christophe Saint Etienne, Fabrice Ivanes, Anne Bernard,
Dominique Babuty, Denis Angoulvant, Laurent Fauchier
Asnières Sur Seine, France
Background: Patients with atrial fibrillation (AF) who undergo percuta-
neous coronary intervention (PCI) and stenting initially require triple anti-
thrombotic therapy according to the current ESC 2010 guidelines. The purpose
of this study was to assess guidelines adherence and detect predictive factors
of the prognosis linked to ESC guidelines adherence and clinical characteris-
tics of this population.
Methods: AF patients referred for PCI with stenting were enrolled since
the year 2011 to 2013. Prescription and chronology of the antithrombotic
treatment (AT), occurrence of bleeding, myocardial ischemia, stroke and death
were obtained by screening hospitalization reports and phone call with stan-
dardized questions during follow-up.
Results: Among 259 AF patients with PCI and stenting (age 76±10 years;
CHA2DS2-VASc score 4.3 ± 1.7), 40% had acute coronary syndrome and 60%
had elective PCI. During 633 ± 352 days follow-up, 53/156 (34%) of those
admitted for elective PCI were guidelines adherent, whilst they were 10/49
(20%) for non ST elevation myocardial infarction (NSTEMI) and 8/54 (15%)
for STEMI. Permanent AF (OR, 0.45; 95%CI 0.23-0.89; p=0.02), history of
valvular heart disease (OR 0.51; 95%CI 0.26-0.98; p=0.04), heart failure (OR
0.49; 95%CI 0.25-0.94; p=0.03) and use of OAC before hospitalization (OR
0.48; 95%CI 0.24-0.96; p=0.04) were associated with guidelines adherence.
OAC and APT underuse were associated with an increased risk of death (OR
3.73; 95%CI 1.47-10.10, p=0.005 and OR 7.35, 95%CI 2.27-26.68, p=0.0009
respectively) whereas APT overtreatment was associated with a significant
lower rate of death (OR 0.23, 95% CI 0.08-0.59, p=0.002). 
Conclusion: Guidelines for antithrombotic therapy in patients with AF
who undergo PCI and stent implantation are still poorly followed in clinical
practice. OAC underused was associated with an increased risk of death in this
population.
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Involvement of protease nexin-1 in the clearance of serine proteases in
human thoracic aneurysms of ascending aorta
Kamel Boukais, Richard Bayles, Liliane Louedec, Hadidja Idhihar, Véro-
nique Arocas, Guillaume Jondeau, Marie-Christine Bouton, Jean-Baptiste
Michel
APHP-Hôpital Bichat-Claude Bernard, INSERM 1148, Paris, France
Tissue activation of proteolysis is involved in progressive dilation and
dissection of human thoracic aneurysms of ascending aorta (TAA).
Vascular smooth muscle cells (VSMC) limit possible proteolytic wall
injury by producing antiproteases, among which is protease nexin-1 (PN-1).
PN-1 is a tissue serpin expressed by VSMC, able to inhibit plasmin acti-
vities by forming complexes. The main objective was to test whether
human VSMC can clear plasmin/PN-1 complex through an LRP1-depen-
dent mechanism.
We have explored the expression of PN-1, t-PA and LRP-1 in human tissue
and cultured VSMC of TAA compared with healthy aorta (control). PN-1,
t-PA and LRP-1 mRNA were overexpressed in medial extracts of TAA com-
pared with control. Both PN-1 and LRP-1 protein were overexpressed in cul-
tured VSMC from TAA as compared to control whereas for t-PA there was
no difference in protein expression between TAA and control. We have
studied the localisation of PN-1/plasmin and LRP-1 in TAA. Intracellular
presence of plasmin, PN-1 and LRP-1 in VSMC in human TAA was detected.
We used cultured VSMC to study their abilitiy to endocytose PN-1 or PN-1/
plasmin complexes. VSMC endocytose PN-1 and PN-1/plasmin complexes
but not plasmin.
Our results suggest that PN-1, t-PA and LRP-1 are increased in order to
protect the arterial wall from protease injury in TAA.
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Delphinidin and calcium signaling in human T lymphocytes: a basis to
elucidate pathways leading to proliferation and apoptosis
Ousama Dayoub, Nicolas Clere, Ramaroson Andriantsitohaina
CHU Angers, INSERM UMR1063, Angers, France
Delphinidin, an anthocyanin present in red wine, has been reported to
exert vasculoprotective properties due to its vasodilatory and antioxidant
effects at the level of the endothelium. However, the effect of delphinidin
on cells involves in inflammation in cardiovascular diseases remains
unknown. We have investigated the effect of delphinidin on the prolifera-
tion and apoptosis of T lymphocytes with respect to calcium signaling.
Human T cells were isolated from blood of healthy patients. Proliferation
was assessed using CyQUANT® NF Cell Proliferation Assay Kit and apop-
tosis by flow cytometry. Calcium signaling was analyzed using Fluo-4
probe and the mechanisms were depicted using appropriate drugs. Delphin-
idin did not modify basal proliferation but it was able to decrease the phy-
tohemagglutinin (PHA)-induced proliferation. Inhibitors of capacitative
entry and estrogen receptor antagonist, fulvestrant, but not the NO-synthase
inhibitor prevented the effect of delphinidin. In addition, delphinidin
reduced actinomycin D-induced apoptosis via a mechanism sensitive to
capacitative entry inhibitors. Interestingly, delphinidin decreased the ability
of thapsigargin to increase both calcium release and entry. The effect of
delphinidin was sensitive to capacitative entry inhibitors and partially pre-
vented by fulvestrant but not by the NO synthase inhibitor. Immuno-
histochemistry analysis showed that delphinidin reduced membrane
translocation of STIM-1, a principal step in capacitative entry activation
through « calcium release activated channels » CRAC. Together, these data
suggest that delphinidin attenuates T lymphocyte activation via multiple
cellular targets on the regulation of calcium signaling via estrogen antago-
nist sensitive and insensitive pathways. The consequence of which results
in inhibition of both proliferation and apoptosis. These effects concur to the
protective effect of delphinidin on processes leading to inflammation asso-
ciated with T lymphocyte activation.
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